Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Plos One
|
June 30, 2017
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations
Lucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Trials
|
April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials
|
July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Plos One
|
July 9, 2019
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease
Emily Baker, Rebecca Sims, Ganna Leonenko, et al.
Health Technology Assessment (Winchester, England)
|
June 20, 2017
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations
Lucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Alzheimer'S Research & Therapy
|
February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Nature Medicine
|
December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial
Paul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Plos One
|
January 26, 2010
Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease
Minerva M Carrasquillo, Olivia Belbin, Fanggeng Zou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 16, 2019
Vascular dysfunction-The disregarded partner of Alzheimer's disease
Melanie D Sweeney, Axel Montagne, Abhay P Sagare, et al.
Plos One
|
June 13, 2014
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease
Valentina Escott-Price, Céline Bellenguez, Li-San Wang, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Plos One
|
June 30, 2017
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations
Lucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Trials
|
April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials
|
July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Plos One
|
July 9, 2019
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease
Emily Baker, Rebecca Sims, Ganna Leonenko, et al.
Health Technology Assessment (Winchester, England)
|
June 20, 2017
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations
Lucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Alzheimer'S Research & Therapy
|
February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Nature Medicine
|
December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial
Paul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Plos One
|
January 26, 2010
Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease
Minerva M Carrasquillo, Olivia Belbin, Fanggeng Zou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 16, 2019
Vascular dysfunction-The disregarded partner of Alzheimer's disease
Melanie D Sweeney, Axel Montagne, Abhay P Sagare, et al.
Plos One
|
June 13, 2014
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease
Valentina Escott-Price, Céline Bellenguez, Li-San Wang, et al.
Page
of 14